BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26122225)

  • 1. HOW EXPRESSIONS OF CLAUDIN-1 AND MMP-2 IN RETINOBLASTOMA CORRELATE WITH HISTOLOGICAL DIFFERENTIATION AND OPTIC NERVE INVASION.
    Wan WC; Jin XM; Zheng GY; Zhang FY; Lv Y; Zhu Y
    J Biol Regul Homeost Agents; 2015; 29(2):373-8. PubMed ID: 26122225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between claudin-1 and PIGF expressions in retinoblastoma.
    Wang HF; Zheng SF; Chen Y; Zhou ZY; Xu J
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4196-4203. PubMed ID: 30024608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invasion of the optic nerve in undifferentiated retinoblastoma].
    Florescu M; Bosun I; Simionescu C
    Oftalmologia; 1996; 40(4):354-6. PubMed ID: 8962864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors.
    Shields CL; Shields JA; Baez K; Cater JR; De Potter P
    Cancer; 1994 Feb; 73(3):692-8. PubMed ID: 8299091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can preoperative MR imaging predict optic nerve invasion of retinoblastoma?
    Song KD; Eo H; Kim JH; Yoo SY; Jeon TY
    Eur J Radiol; 2012 Dec; 81(12):4041-5. PubMed ID: 23017191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion of the optic nerve by retinoblastoma: a clinicopathological study.
    Rootman J; Hofbauer J; Ellsworth RM; Kitchen D
    Can J Ophthalmol; 1976 Apr; 11(2):106-14. PubMed ID: 1078326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
    Khelfaoui F; Validire P; Auperin A; Quintana E; Michon J; Pacquement H; Desjardins L; Asselain B; Schlienger P; Vielh P
    Cancer; 1996 Mar; 77(6):1206-13. PubMed ID: 8635145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of C-kit in retinoblastoma: a potential therapeutic target.
    Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
    Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases.
    Stannard C; Lipper S; Sealy R; Sevel D
    Br J Ophthalmol; 1979 Aug; 63(8):560-70. PubMed ID: 476032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the risk factors for optic nerve invasion in 381 cases of retinoblastoma].
    Ren RJ; Li B; Li LQ; Sun XL
    Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):489-92. PubMed ID: 17897523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
    Youssef NS; Said AM
    Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
    Adithi M; Nalini V; Kandalam M; Krishnakumar S
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.
    Brisse HJ; Guesmi M; Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Desjardins L; Doz F; Asselain B; Bours D; Neuenschwander S
    Pediatr Radiol; 2007 Jul; 37(7):649-56. PubMed ID: 17479257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of histological criteria (TpNM classification, degree of differentiation) on mortality of patients with retinoblastoma].
    Lommatzsch PK; Morgenstern B
    Klin Monbl Augenheilkd; 1992 Apr; 200(4):284-8. PubMed ID: 1614090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma].
    Baez KA; Ulbig MW; Cater J; Shields CL; Shields JA
    Ophthalmologe; 1994 Dec; 91(6):796-800. PubMed ID: 7849434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma.
    Adithi M; Venkatesan N; Kandalam M; Biswas J; Krishnakumar S
    Exp Eye Res; 2006 Dec; 83(6):1446-52. PubMed ID: 17027002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.